A Study of Association Between Amniotic Fluid Index in Third Trimester and Fetomaternal Outcome at a Tertiary Care Centre
International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)
DOI: 10.25258/ijcpr.18.6.98 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von Chaudhari Jigarkumar Jivrambhai und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Amniotic fluid volume is a key indicator of fetal well-being, particularly in the third trimester, where abnormalities often reflect placental insufficiency and fetal compromise. The amniotic fluid index (AFI) is a simple, non-invasive ultrasonographic method widely used for antenatal surveillance. Abnormal AFI has been associated with adverse fetomaternal outcomes, necessitating evaluation in tertiary care settings.
Objectives
To assess the association between third-trimester amniotic fluid index and fetomaternal outcomes in pregnant women attending a tertiary care centre.
Methods
This prospective observational study was conducted in the Department of Obstetrics and Gynaecology at T.S. Misra Medical College and Hospital, Lucknow, from July 2024 to June 2025. A total of 100 pregnant women with singleton pregnancies and gestational age ≥28 weeks were enrolled after applying inclusion and exclusion criteria. AFI was measured using the four-quadrant technique described by Phelan JP between 28 weeks and delivery. Participants were categorized into normal AFI, oligohydramnios, and polyhydramnios groups. Maternal outcomes (mode of delivery, prolonged labour, postpartum hemorrhage) and fetal/neonatal outcomes (birth weight, APGAR scores, need for resuscitation, NICU admission, and complications) were recorded. Statistical analysis was performed, with p < 0.05 considered statistically significant.
Results
Among the participants, 83% had normal AFI, 14% had oligohydramnios, and 3% had polyhydramnios. Maternal age, parity, socioeconomic status, gestational age, and obstetric history showed no significant association with AFI. However, pre-existing maternal medical disorders and previous caesarean section were significantly associated with abnormal AFI. Abnormal AFI demonstrated a strong association with non-reassuring fetal heart rate patterns (p < 0.001), and all such cases required caesarean delivery (p < 0.001). Maternal complications, particularly prolonged labour and postpartum hemorrhage, were significantly higher in abnormal AFI groups. Neonates in these groups had lower birth weight, reduced APGAR scores, increased need for resuscitation, and higher NICU admission rates (p < 0.001). All mothers and neonates were discharged in stable condition.
Conclusion
Abnormal third-trimester AFI, particularly oligohydramnios, is significantly associated with adverse fetomaternal outcomes. Routine AFI assessment is a valuable, non-invasive tool for early identification of high-risk pregnancies and timely obstetric intervention.
Zitieren
APA
Jivrambhai, C. J., Prasad, A., Sinha, N., & Mishra, S. (2026). A Study of Association Between Amniotic Fluid Index in Third Trimester and Fetomaternal Outcome at a Tertiary Care Centre. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.98
Vancouver
Jivrambhai CJ, Prasad A, Sinha N, Mishra S. A Study of Association Between Amniotic Fluid Index in Third Trimester and Fetomaternal Outcome at a Tertiary Care Centre. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.98
BibTeX
@article{Jivrambhai2026,
author = {Jivrambhai, Chaudhari Jigarkumar and Prasad, Anima and Sinha, Namrata and Mishra, Shalini},
title = {A Study of Association Between Amniotic Fluid Index in Third Trimester and Fetomaternal Outcome at a Tertiary Care Centre},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {06},
doi = {10.25258/ijcpr.18.6.98}
}
EUVIMED